The treatment outcome of Glycemic Control in Type 2 Diabetes in Lamphun hospital
Keywords:
เบาหวาน, ฮีโมโกลบินเอวันซี, การควบคุมระดับน้ำตาลAbstract
The purpose of this study is determine the pattern and outcome of oral hypoglycemic agent usage in 55 -type 2 diabetics (T2 DM ) who attended the diabetes clinic in Lamphun Hospital during January 2007 to July 2007. The majority of T2 DM were primary level educated. (67.3%) The most interval age was 40- 59 year. (58%)The average weight was 60.44 Kilogram. About 45.5% were overweight. The overwrist were 54.5 %. 98.2% were Smoking. 50.9% had hypertention and 36.4 % had dyslipidemia. The oral hypoglycemic drugs were use in monotherapy, The usage of glibencamide , glipizide and metformin were 67, 24,9 % in sequencely. T2 DM with hypertention would deceived antihypertensive drug .Only 21.8 % of T2 DM achieved HbA1C less than 6.5% but the percentage of risk characteristic factors such as overweight, over-BMI. were not decrease. Although the objective of Diabetic treatment was to control blood glucose level but the hypoglycemic agent usage was not only the single method. But non-Pharmaceutical interventions such as risk behavioral change were the crucial measures to promote the diabetes care, as well.
References
Bailey CJ, Dell Prato S, Eddy, Zinman B on ofbehalf of the global partnership for effective diabetes management. Earlier intervention in type 2diabetes: the case for achieving early and sustained glycemic control. Int J Clin Pract 2003; 59: 1309-316.
Hypertention in diabtes Study (HDS): I. Prevalence of hypertention in newly presenting typee 2 diabetic patients and association with risk factors for cardiovascular and diabetic complications. J Hypertens 1993; 11:309-17.
วิชัย เอกพลากร. การประเมินความเสี่ยงต่อเบาหวาน.สถานการณ์สุขภาพประเทศไทย, 2549; 8: 1-6.
UKPDS group. UK Prospective Diabetes Study 6.Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors. Diabetes Res 1990; 13: 1-11.
Intensive blood-glucose control with sulphonylureas insulin compared with conventional. Standards of medical care in diabetes. Diabetes Care 2005; n28(Suppl 1): S4-36.
Treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 837-53.
Aekplakorn W, Cheepudomwit S, Bunnag P, et al. A risk score for predicting incident diabetes in the Thai population. Diabetes Care 2006; 29: 1872-7.
American Diabetes Association. Standards of medical care in diabetes-2008. Diabetes Care 2008; 31(suppl1): S12-S54.
Clinical Guideline Task Force. Global guideline for type 2 diabetes. International Diabetes Federation 2005.
Natapong K, Sirima M, Nattachet P, et al. Thailand Diabetes Registry Project: Glycemic Control. In Thai Type 2 Diabetes and Its Relation to Hypoglycemic Agent Usage. J Med Assoc Thai 2006; 89 (Suppl 1): S66-71.
Aekplakorn W, Bunnag P, Woodward M, Sritara P, Cheepudomwit S, Yamwong S, et al. A risk score for predicting incident diabetes in the Thai population. Diabetes Care 2006; 29: 1872-7.
H, Saitoh S, Takagi S, Katoh N, Chiba Y, Akasaka H, et al. Incidence of type 2 diabetes in individuals with central obesity in a rural Japanese population: The Tanno and Sobetsu study. Diabetes Care 2006;29:1128-9.
Agardh EE, Ahlbom A, Andersson T, Efendic S, Grill V, Hallqvist J, et al. Work stress and low sense of coherence is associated with type 2 diabetes in middle-aged Swedish women. Diabetes Care 2003;26: 719-24.
Sullivan PW, Morrato EH, Ghushchyan V, WyattHR, Hill JO. Obesity, inactivity, and the prevalence of diabetes and diabetesrelated cardiovascular comorbidities in the U.S., 2000-2002. Diabetes Care 2005; 28:1599-603.
